GlassScriptPhysician profile
Jose L Rivero
NPI 1801871264
$690.23
in general payments reported to CMS, 2019-2025
14 companies · $29.11 in 2025
The $29.11 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $171 · 2021: $12.79 · 2022: $117 · 2023: $18.75 · 2025: $29.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $47.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $47.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $317.00 | 2019-2023 | Lo Loestrin Fe |
| Coopersurgical, INC. | $61.10 | 2019-2020 | |
| Aspira Women'S Health INC | $55.98 | 2022 | |
| Organon LLC | $37.39 | 2022 | |
| Mylan Pharmaceuticals INC. | $37.25 | 2019-2020 | |
| Allergan, INC. | $36.82 | 2019-2020 | |
| Medtronic, INC. | $29.11 | 2025 | Truclear |
| Daiichi Sankyo INC. | $23.62 | 2022 | |
| Boston Scientific Corporation | $19.66 | 2019 | |
| Covidien LP | $16.99 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.68 | 2019 | |
| Astellas Pharma US INC | $15.51 | 2019 | |
| Avion Pharmaceuticals | $12.79 | 2021 | |
| Exeltis, USA INC. | $11.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Rivero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.